// App-Quantinova.ai

FRI0212 (2017) : COMPARATIVE EFFECTIVENESS OF FIRST-LINE BIOLOGIC MONOTHERAPY IN RHEUMATOID ARTHRITIS

Researchers

Presenter

  • E. Silvagni

Principal Investigators

  • A. Bortoluzzi

  • G. Carrara

  • M. Govoni

  • C. Scir

Medical Centers

  • Department of Medical Science, Rheumatology Unit, University of Ferrara and Azienda Ospedaliero-Universitaria San-Anna, Cona Ferrara, Italy

  • Epidemiology Unit, Italian Society for Rheumatology

  • Epidemiology Unit Italian Society for Rheumatology (SIR), Milano, Italy

Locations

  • Italy

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • N/A

Biomarkers

  • TNF Receptor Superfamily Member 1B

  • Interferon

Drug/Treatment

  • Hydroxychloroquine

  • Glucocorticoid

  • Sulfasalazine

  • Certolizumab pegol

  • Cyclosporine eent

  • Methotrexate

  • Tocilizumab

  • HWA-486

  • Adalimumab

  • Infliximab

  • Etanercept

  • CHS-0214

  • Abatacept

  • golimumab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved